Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 24, Issue 6, Pages 795-804
Publisher
SAGE Publications
Online
2017-05-09
DOI
10.1177/1352458517707345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Information processing speed in multiple sclerosis: Past, present, and future
- (2016) Silvana L Costa et al. Multiple Sclerosis Journal
- Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients
- (2016) Niels Bergsland et al. Multiple Sclerosis Journal
- Information processing speed in multiple sclerosis: Past, present, and future
- (2016) Silvana L Costa et al. Multiple Sclerosis Journal
- Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients
- (2016) Niels Bergsland et al. Multiple Sclerosis Journal
- Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab
- (2016) Malte Roar et al. Multiple Sclerosis and Related Disorders
- Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis
- (2015) Ludwig Kappos et al. JOURNAL OF NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial
- (2014) Naghmeh Mokhber et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Characterizing cognitive function during relapse in multiple sclerosis
- (2014) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects
- (2013) A. Minagar et al. NEUROLOGY
- Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study
- (2013) Francesco Patti et al. PLoS One
- Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
- (2012) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
- (2011) Bianca Weinstock-Guttman et al. JOURNAL OF NEUROLOGY
- Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
- (2011) DW Langdon et al. Multiple Sclerosis Journal
- Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline
- (2010) Sarah A. Morrow et al. CLINICAL NEUROPSYCHOLOGIST
- Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
- (2010) SA Morrow et al. Multiple Sclerosis Journal
- The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study
- (2010) Flavia Mattioli et al. NEUROLOGICAL SCIENCES
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis
- (2009) F. Patti et al. Multiple Sclerosis Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started